Skip to main content
logo

Centogene N.V. (CNTGF)

OTCMKTS · Delayed Price · Currency is USD
0.1200
0.00 (0.00%)
Inactive · Last trade price on May 22, 2026
Market Cap3.80M -10.9%
Revenue (ttm)53.65M +2.2%
Net Income-39.27M
EPS-1.40
Shares Out n/a
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume22,760
Open0.1060
Previous Close0.1200
Day's Range0.1060 - 0.1200
52-Week Range0.0003 - 0.7050
Beta0.16
Analystsn/a
Price Targetn/a
Earnings Daten/a

About Centogene

Centogene N.V., together with its subsidiaries, provides pharmaceutical solutions and diagnostic tests in Europe, the Middle East, North America, Latin America, and the Asia Pacific. The company offers data-driven answers to patients, physicians, and pharmaceutical companies for rare and neurodegenerative diseases. It provides CENTOGENE MOx 2.0, a single-step multiomic solution that combines DNA sequencing, biochemical testing, and RNA sequencing; CentoCloud, a cloud-based Software as a Service platform, which enables laboratories to analyze, i... [Read more]

Industry Diagnostics & Research
Sector Healthcare
Founded 2006
Employees 384
Stock Exchange OTCMKTS
Ticker Symbol CNTGF
Full Company Profile

Financial Performance

In 2023, Centogene's revenue was 48.54 million, an increase of 2.24% compared to the previous year's 47.47 million. Losses were -35.53 million, 11.6% more than in 2022.

Financial numbers in EUR Financial Statements